AMR and health inequalities data
Link between antimicrobial resistance (AMR) and health inequalities, with limited routine data collection on this issue.
7 items
1 source
2 inquiries
Source spread
Where this theme appears
AMR and health inequalities data has been flagged across 1 independent accountability source:
7 inquiry recs
This theme has been identified in one data source. As more data is added, cross-references may emerge.
Browse by source
Source-grouped records are useful for tracing where a concern came from. Large sections show the 50 strongest matches for that source; counts still show the full theme total.
Inquiry Recommendations (7)
R40 — Prudent antibiotic prescribing
Recommendation: Health Boards should ensure that the key principles of prudent antibiotic prescribing are adhered to and that implementation of policy is rigorously monitored by management.
Gov response: Section 2.1 of the Scottish Government's response emphasizes the major role of prudent antibiotic prescribing in HAI prevention and control. The HAI Taskforce addresses this by developing guidelines, including an antimicrobial prescribing policy for Scotland …
Accepted
R35 — Antibiotic prescribing monitoring
Recommendation: Scottish Government should monitor the implementation of policies and/or guidance on antibiotic prescribing issued in connection with healthcare associated infection.
Gov response: Section 2.1 of the Scottish Government's response details several mechanisms for monitoring the implementation of antibiotic prescribing policies. The HAI Taskforce established the Controlling Antimicrobial Resistance in Scotland Group to oversee activity and produce outcome …
Accepted
R34 — Antimicrobial guidance implementation
Recommendation: Health Boards should ensure that changes in policy and/or guidance on antimicrobial practice issued by or on behalf of Scottish Government are implemented without delay.
Gov response: Section 2.1 of the Scottish Government's response outlines that the HAI Taskforce develops guidelines to improve antimicrobial prescribing practices, including an antimicrobial prescribing policy for Scotland and the Scottish Management of Antimicrobial Resistance Action Plan …
Accepted
COVID-M4.3 — Improve Vaccine Uptake Monitoring and Evaluation
Recommendation: Each of the four UK public health or health security agencies should work together to: maintain accurate, UK-wide insight into the state of vaccine uptake and hesitancy; and understand the measures proven to be effective in increasing uptake across the …
Gov response: No formal response published by this government.
Unknown
COVID-M4.2 — Formalise Community Vaccine Equity Networks
Recommendation: The UK government, Scottish Government, Welsh Government and Northern Ireland Executive should maintain networks with local communities to produce targeted vaccination strategies and communications. To achieve this: The Scottish Government, Welsh Government and Northern Ireland Executive should establish local community …
Gov response: No formal response published by this government.
Unknown
R41 — Laboratory specimen processing
Recommendation: Health Boards should ensure that there is no unnecessary delay in processing laboratory specimens, in reporting positive results and in commencing specific antibiotic treatment.
Gov response: Section 3.2 of the Scottish Government's response highlights that NHS board antimicrobial management teams (AMTs) drive comprehensive approaches to education on antimicrobial stewardship for clinical staff and promote application of antimicrobial policies. Section 4.2 details …
Accepted
R37 — CDI senior assessment and treatment
Recommendation: Health Boards should ensure that any patient with suspected CDI receives full clinical assessment by senior medical staff, that specific antibiotic therapy for CDI is commenced timeously.
Gov response: Section 4.1 of the Scottish Government's response acknowledges that recommendation 37 addresses delays in diagnosing and treating C. diff infection. Section 2.1 details that Scotland's Health Protection Network published C. diff guidance, revised in 2014, …
Accepted